PETS

Petmed Express Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth 0/10
  • Momentum 6/10
Petmed Express sales and earnings growth
PETS Growth
Low
  • Revenue Y/Y -22.51%
  • EPS Y/Y -31300.00%
  • FCF Y/Y -2780.82%
Petmed Express gross and profit margin trends
PETS Profitability
Low
  • Gross margin 30.20%
  • EPS margin -35.50%
  • ROIC 1470.30%
Petmed Express net debt vs free cash flow
PETS Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage -78.4

Petmed Express stock volatility is in-line with the overall market. We give it a Great risk rating.

More Pharmaceutical Retailers stocks ↗